These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. HSF1 deficiency accelerates the transition from pressure overload-induced cardiac hypertrophy to heart failure through endothelial miR-195a-3p-mediated impairment of cardiac angiogenesis. Wang S; Wu J; You J; Shi H; Xue X; Huang J; Xu L; Jiang G; Yuan L; Gong X; Luo H; Ge J; Cui Z; Zou Y J Mol Cell Cardiol; 2018 May; 118():193-207. PubMed ID: 29626503 [TBL] [Abstract][Full Text] [Related]
9. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Wang K; Liu F; Zhou LY; Long B; Yuan SM; Wang Y; Liu CY; Sun T; Zhang XJ; Li PF Circ Res; 2014 Apr; 114(9):1377-88. PubMed ID: 24557880 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-327 regulates cardiac hypertrophy and fibrosis induced by pressure overload. Ji Y; Qiu M; Shen Y; Gao L; Wang Y; Sun W; Li X; Lu Y; Kong X Int J Mol Med; 2018 Apr; 41(4):1909-1916. PubMed ID: 29393356 [TBL] [Abstract][Full Text] [Related]
11. Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis. Xu Q; Lekgabe ED; Gao XM; Ming Z; Tregear GW; Dart AM; Bathgate RA; Samuel CS; Du XJ Endocrinology; 2008 Feb; 149(2):476-82. PubMed ID: 17991721 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload. Bernardo BC; Nguyen SS; Gao XM; Tham YK; Ooi JY; Patterson NL; Kiriazis H; Su Y; Thomas CJ; Lin RC; Du XJ; McMullen JR Sci Rep; 2016 Mar; 6():22442. PubMed ID: 26928825 [TBL] [Abstract][Full Text] [Related]
14. Dec1 deficiency protects the heart from fibrosis, inflammation, and myocardial cell apoptosis in a mouse model of cardiac hypertrophy. Li X; Le HT; Sato F; Kang TH; Makishima M; Zhong L; Liu Y; Guo L; Bhawal UK Biochem Biophys Res Commun; 2020 Nov; 532(4):513-519. PubMed ID: 32896382 [TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Izumiya Y; Shiojima I; Sato K; Sawyer DB; Colucci WS; Walsh K Hypertension; 2006 May; 47(5):887-93. PubMed ID: 16567591 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-21 is involved in direct actions of ursolic acid on the heart: implications for cardiac fibrosis and hypertrophy. Dong X; Liu S; Zhang L; Yu S; Huo L; Qile M; Liu L; Yang B; Yu J Cardiovasc Ther; 2015 Aug; 33(4):161-7. PubMed ID: 25903305 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure. Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828 [TBL] [Abstract][Full Text] [Related]